CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
t:slim X2 insulin pump with Tandem Freedom Algorithmdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06834568
NCT06834568N/ACompleted
CompareCT.gov

Tandem Freedom - Feasibility Trial 2

Tandem Diabetes Care, Inc.·interventional·Posted Feb 19, 2025·Updated May 5, 2026

In Brief

A clinical study evaluating t:slim X2 insulin pump with Tandem Freedom Algorithm for Diabetes Mellitus, Type 1. Completed, enrolled 10 participants across 1 site.

Detailed Summary

This feasibility study is a prospective, single arm study evaluating the Tandem Freedom system in adults with type 1 diabetes. Existing Control-IQ technology users will use Control-IQ technology at home for a one week run-in, then will use Tandem Freedom in a supervised hotel setting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 1
CountriesNew Zealand
Collaborators--

Timeline

N/ACompletedFinished
2026
First PostedFeb 19, 2025
Enrollment StartMar 24, 2025
Primary CompletionApr 7, 2025
TodayJul 2, 2026
Enrollment to primary: 13 daysPosted 1.4 years ago

Interventions

t:slim X2 insulin pump with Tandem Freedom Algorithmdevice

t:slim X2 insulin pump with Tandem Freedom System consists of the Tandem t:slim X2 insulin pump and the Freedom algorithm embedded in the pump. Participants will also use the Dexcom G6 continuous glucose monitoring system.